GoKawiilUnapproved Weight-Loss Drug Retatrutide Sold Illegally Despite Lacking Regulatory Approval
Retatrutide, an experimental weight-loss drug not yet approved by any regulator, is reportedly being sold through unregulated channels alongside other peptides. Companies are distributing the compound outside normal pharmaceutical oversight, raising concerns about product safety and quality control.